MXC.AX - MGC Pharmaceuticals Limited

ASX - ASX Delayed price. Currency in AUD
Currency in AUD

Valuation measures

Market cap (intra-day) 523.31M
Enterprise value 324.15M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)10.85
Price/book (mrq)4.25
Enterprise value/revenue 311.25
Enterprise value/EBITDA 6-2.07

Trading information

Stock price history

Beta (5Y monthly) 1.23
52-week change 3-51.43%
S&P500 52-week change 3-14.06%
52-week high 30.0670
52-week low 30.0150
50-day moving average 30.0216
200-day moving average 30.0312

Share statistics

Avg vol (3-month) 32.41M
Avg vol (10-day) 3N/A
Shares outstanding 51.4B
Float 1.18B
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 321 Aug 2012

Financial highlights

Fiscal year

Fiscal year ends 30 Jun 2019
Most-recent quarter (mrq)31 Dec 2019

Profitability

Profit margin 0.00%
Operating margin (ttm)-559.48%

Management effectiveness

Return on assets (ttm)-60.43%
Return on equity (ttm)-89.73%

Income statement

Revenue (ttm)2.15M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)521.00%
Gross profit (ttm)299.6k
EBITDA -11.68M
Net income avi to common (ttm)-8.39M
Diluted EPS (ttm)-0.0070
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.03M
Total cash per share (mrq)0
Total debt (mrq)1.89M
Total debt/equity (mrq)36.38
Current ratio (mrq)1.04
Book value per share (mrq)0.00

Cash flow statement

Operating cash flow (ttm)-9.56M
Levered free cash flow (ttm)-4.62M